- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
OHSU’s Dr Andrew McHill Discusses How Best to Optimize Sleep Hygiene Practices
In this interview from SLEEP 2023, Andrew McHill, PhD, of Oregon Health and Science University (OHSU), explains the importance of individualizing sleep hygiene recommendations.
It’s important to make recommendations based on an individual's biological clock, considering also sleep variability and how that affects the circadian system, noted Andrew McHill, PhD, an assistant professor at Oregon Health and Science University.
In this interview from SLEEP 2023, he explains the importance of individualizing sleep hygiene recommendations.
Transcript
Can you discuss how evidence-based behavioral interventions and sleep hygiene practices be optimized to the individual?
What we've tried to do is we've tried to look at each individual's internal biological clock, or their circadian clock, and try to make recommendations based on that clock so we can time certain things relative to that timing, instead of just saying it works for everyone. And I think sleep hygiene practices can really fit into that as well.
Another newer branch of the science is sleep variability. So looking at the timing of sleep and the regularity of that timing of sleep, in addition to the duration, and just timing relative to your circadian system as well. So keeping a very regular schedule may be just as important as getting enough sleep, we think.
AI, GLP-1s Among Topics to Be Discussed During ASPC Annual Meeting
July 28th 2025The American Society for Preventive Cardiology (ASPC) Congress on Cardiovascular Disease Prevention features multiple sessions on different methods of treating and preventing cardiovascular disease, including through the use of artificial intelligence (AI) and glucagon-like peptide-1 (GLP-1) receptor agonists.
Read More
Across 8 Trials, Ruxolitinib Cream Shows Favorable Safety in Pediatric AD
July 25th 2025A poster at the Society for Pediatric Dermatology Annual Meeting presented an integrated safety analysis showing rare or no serious adverse events linked to topical Janus kinase inhibitor use in children with atopic dermatitis (AD).
Read More
